About Us

Driven by innovation, collaboration, and excellence, BioVision dedicates itself to expanding access to advanced biologics by manufacturing treatments directly in the global south, addressing critical healthcare needs with precision and impact... 

Driven by innovation, collaboration, and excellence, BioVision dedicates itself to expanding access to advanced biologics by manufacturing treatments directly in the global south, addressing critical healthcare needs with precision and impact... 

Our Portfolio

Our partner, The Bio Investments Group, has licensed or is in the process of finalizing license agreements for several biologics, vaccines, and in-vitro diagnostics. These agreements includes the transfer of full technolgy, fill finish and bulk drug substance manufacturing, testing and release. Here is a limited selection of licensed assets: 

Our partner, The Bio Investments Group, has licensed or is in the process of finalizing license agreements for several biologics, vaccines, and in-vitro diagnostics. These agreements includes the transfer of full technolgy, fill finish and bulk drug substance manufacturing, testing and release. Here is a limited selection of licensed assets: 

Type

Assets

Biotherapeutics

Infliximab Adalimumab Rituximab Bevacizumab PD1 Trastuzumab

Biotherapeutics

Infliximab Adalimumab Rituximab Bevacizumab PD1 Trastuzumab

Biotherapeutics

Infliximab Adalimumab Rituximab Bevacizumab PD1 Trastuzumab

Vaccines

Hexavalent Vaccine MMR (Measles, Mumps, Rubella) Vaccine Hepatitis B Vaccine Hepatitis A Vaccine HPV (Human Papillomavirus) Vaccine Influenza Vaccine Varicella (Chickenpox) Vaccine Pneumococcal Conjugate Vaccines (PCV)

Vaccines

Hexavalent Vaccine MMR (Measles, Mumps, Rubella) Vaccine Hepatitis B Vaccine Hepatitis A Vaccine HPV (Human Papillomavirus) Vaccine Influenza Vaccine Varicella (Chickenpox) Vaccine Pneumococcal Conjugate Vaccines (PCV)

Vaccines

Hexavalent Vaccine MMR (Measles, Mumps, Rubella) Vaccine Hepatitis B Vaccine Hepatitis A Vaccine HPV (Human Papillomavirus) Vaccine Influenza Vaccine Varicella (Chickenpox) Vaccine Pneumococcal Conjugate Vaccines (PCV)

In-Vitro Diagnostics

Infectious Disease Tests Sexual Health Tests Tropical and Parasitic Disease Tests Respiratory Infection Tests Gastrointestinal Infection Tests Cardiac Marker Tests Pregnancy and Fertility Tests

In-Vitro Diagnostics

Infectious Disease Tests Sexual Health Tests Tropical and Parasitic Disease Tests Respiratory Infection Tests Gastrointestinal Infection Tests Cardiac Marker Tests Pregnancy and Fertility Tests

In-Vitro Diagnostics

Infectious Disease Tests Sexual Health Tests Tropical and Parasitic Disease Tests Respiratory Infection Tests Gastrointestinal Infection Tests Cardiac Marker Tests Pregnancy and Fertility Tests

New Projects

Saudi Arabia Facility

Saudi Arabia Facility

Founded in our mission to provide equitable access to biotherapeutics in the global south,
BioVision and The Bio Investments Group have partnered with the Kingdom to build a state-of-the-art facility...

Whether it’s developing a brand identity, creating a user-friendly website, or executing a dynamic marketing campaign, we approach every project with the same level of dedication and enthusiasm. “

Project Name:

Bio-Manufacture Facility - Saudi Arabia

Description

The Bio Investments Group recently received state approval for a bio-manufacturing facility in Saudi Arabia. With an annual production capacity of 20 million to 30 million doses, this facility will be a hallmark example of the Kingdom's national strategy to produce treatments locally.

Industry:

Biotherapeutics

Release Date:

Est. Q1 2026

Learn More

Learn More

Learn More

Leadership Team

Rob Thomas

Partner & CEO for BioVision

Mr. Thomas is the CEO of BioVision and leads our business development efforts. He has many years of experience leading organizations in user experience and was previously the VP of Commercialization Strategy for The Bio Investments Group.

Tyler Morrey

Partner & COO for BioVision

Mr. Morrey leads licensing for BioVision as an experienced executive and valuation expert. He brings deep consulting experience from his work on license agreements for publicly traded biotechnology and pharamaceutical companies.

Jordan Volz, CPA

Partner & CFO for BioVision

Mr. Volz acts as the CFO for BioVision and brings many years of experience as an executive and a certified public accountant, consulting with large-cap public companies in healthcare and other industries on financial reporting matters and IPOs.